ArticleDrug design, development and therapy2022

Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients.

Marwa S Hamza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.